{
  "documentMetadata": {
    "title": "Cat-scratch Disease (CSD)",
    "sourceFile": "lymph_nodes-spleen/lymphadenitis/Cat-scratch Disease (CSD).pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "paragraph",
      "text": "Most common clinical syndrome is self-limited regional lymphadenitis after contact between an immunocompetent patient and a cat, especially a young feral or domestic cat. Occurs with or without disseminated infection."
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Other clinical manifestations:"
        },
        {
          "type": "list",
          "items": [
            "Disseminated cat-scratch disease: Hepatosplenic cat-scratch infection",
            "Neurologic cat-scratch infection: Encephalopathy most common, Transverse myelitis, radiculitis, cerebellar ataxia all reported",
            "Ocular cat scratch infection: Parinaud's ocular glandular syndrome, Optic neuritis, neuroretinitis",
            "Other manifestations: fever of unknown origin (FUO) (rare) (Clin Infect Dis 2020, 71:2818), culture negative endocarditis, arthritis, osteomyelitis"
          ]
        }
      ]
    },
    {
      "type": "paragraph",
      "text": "Recommend treatment of all patients in order to shorten duration of illness and reduce risk of complications."
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Distribution of inflamed nodes:"
        },
        {
          "type": "list",
          "items": [
            "Axillary/epitrochlear (46%)",
            "Neck (26%)",
            "Inguinal (17%)",
            "Suppuration (10%)"
          ]
        }
      ]
    },
    {
      "type": "paragraph",
      "text": "Disseminated disease manifestations occur in 14% of patients."
    },
    {
      "type": "header",
      "level": 1,
      "text": "Diagnosis"
    },
    {
      "type": "list",
      "items": [
        "History of cat or cat-flea contact",
        "Positive antibody test for Bartonella henselae. Titer â‰¥ 1:512"
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Other rarely used diagnostic methods:"
        },
        {
          "type": "list",
          "items": [
            "PCR on node aspirate or biopsy with granulomas",
            "Warthin-Starry silver stain."
          ]
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiology"
    },
    {
      "type": "list",
      "items": [
        "Bartonella henselae: Slow growing fastidious gram-negative bacillus"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Lymphadenitis in immunocompetent patient."
        },
        {
          "type": "paragraph",
          "text": "Often resolves without treatment."
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult"
            },
            "components": [
              {
                "drug": "Azithromycin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "x 1 dose, then 250 mg po/day"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4 days"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Child (Weight < 45 kg)"
            },
            "components": [
              {
                "drug": "Azithromycin oral solution",
                "dose": "10 mg/kg",
                "route": "po",
                "frequency": "x 1 dose, then 5 mg/kg/day po"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4 days"
            }
          }
        },
        {
          "type": "paragraph",
          "text": "If intolerant to Azithromycin, can treat symptoms and avoid anti-infectives."
        }
      ]
    },
    {
      "type": "procedure",
      "procedureData": {
        "name": "Needle aspiration of purulent exudate from suppurative nodes",
        "indication": "Pain relief"
      }
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Hepatosplenic or disseminated infection:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult, preferred regimen"
            },
            "components": [
              {
                "drug": "Rifampin",
                "dose": "300 mg",
                "route": "IV/po",
                "frequency": "bid"
              },
              {
                "drug": "Azithromycin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "x one dose, then 250 mg/day",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "10-14 days"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult, alternative regimen"
            },
            "components": [
              {
                "drug": "Rifampin",
                "dose": "300 mg",
                "route": "IV/po",
                "frequency": "bid"
              },
              {
                "drug": "Gentamicin",
                "dose": "2 mg/kg",
                "frequency": "x one dose and then 1.5 mg/kg q8h",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "10-14 days"
            }
          }
        },
        {
          "type": "paragraph",
          "text": "Consider adjunctive corticosteroids for severe or persistent infection"
        }
      ]
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Neurologic and/or ocular (neuroretinitis) infection: collaborative care with ophthalmology"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult preferred regimen"
            },
            "components": [
              {
                "drug": "Doxycycline",
                "dose": "100 mg",
                "route": "IV/po",
                "frequency": "bid"
              },
              {
                "drug": "Rifampin",
                "dose": "300 mg",
                "route": "IV/po",
                "frequency": "bid",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4-6 weeks"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult, alternatives"
            },
            "components": [
              {
                "drug": "Rifampin"
              },
              {
                "drug": "Azithromycin",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4-6 weeks"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Adult, alternatives"
            },
            "components": [
              {
                "drug": "Rifampin"
              },
              {
                "drug": "TMP-SMX-DS",
                "dose": "one",
                "route": "po",
                "frequency": "bid",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4-6 weeks"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "appliesTo": {
              "description": "Child (age < 8 yrs)"
            },
            "components": [
              {
                "drug": "Azithromycin",
                "dose": "10 mg/kg on day 1, then 5 mg/kg/day"
              },
              {
                "drug": "TMP-SMX",
                "dose": "8 mg/kg/day (TMP comp) in 2 divided doses",
                "connector": "or"
              },
              {
                "drug": "Rifampin",
                "dose": "10 mg/kg",
                "frequency": "q12h",
                "connector": "+"
              }
            ],
            "durationDetail": {
              "fixedDuration": "4-6 weeks"
            },
            "notes": "(max 600 mg/day)"
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Prednisone",
                "dose": "1 mg/kg/day",
                "route": "po"
              }
            ],
            "durationDetail": {
              "fixedDuration": "2 weeks and then taper over the following 4 weeks"
            },
            "notes": "Recommend adjunctive corticosteroids"
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Lymphadentis. Other drugs with in vitro activity:"
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Clarithromycin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-10 days"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Rifampin",
                "dose": "300 mg",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-10 days"
            },
            "notes": "Remember to check for drug-drug interactions."
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "TMP-SMX DS",
                "dose": "one",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-10 days"
            }
          }
        },
        {
          "type": "drugRegimen",
          "regimenData": {
            "intent": "treatment",
            "components": [
              {
                "drug": "Ciprofloxacin",
                "dose": "500 mg",
                "route": "po",
                "frequency": "bid"
              }
            ],
            "durationDetail": {
              "fixedDuration": "7-10 day"
            }
          }
        }
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "paragraph",
      "text": "Uncomplicated adenitis in children usually resolves without treatment, although one study showed faster resolution with azithromycin (Ped Infect Dis J 1998; 17:447). Joint decision making about benefits and downsides of treatment is reasonable."
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "Jarisch-Herxheimer reactions have occurred after the first few doses of antibiotic.",
        "Remember to check for drug-drug interactions in patients given Rifampin.",
        "Review: Pediatr Infect Dis J 2021,40:S11."
      ]
    }
  ]
}
